1. Home
  2. RVMD vs TS Comparison

RVMD vs TS Comparison

Compare RVMD & TS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$189.23

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Logo Tenaris S.A.

TS

Tenaris S.A.

HOLD

Current Price

$57.39

Market Cap

27.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
TS
Founded
2014
2001
Country
United States
Luxembourg
Employees
883
24875
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
30.1B
27.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RVMD
TS
Price
$189.23
$57.39
Analyst Decision
Strong Buy
Buy
Analyst Count
19
5
Target Price
$140.84
$58.80
AVG Volume (30 Days)
1.8M
1.0M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
2.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.53
Revenue Next Year
$533.02
$3.59
P/E Ratio
N/A
$12.59
Revenue Growth
N/A
N/A
52 Week Low
$34.00
$33.71
52 Week High
$194.56
$64.60

Technical Indicators

Market Signals
Indicator
RVMD
TS
Relative Strength Index (RSI) 55.41 51.39
Support Level $176.00 $57.16
Resistance Level $193.83 $59.12
Average True Range (ATR) 7.45 1.19
MACD -0.96 0.20
Stochastic Oscillator 58.24 55.98

Price Performance

Historical Comparison
RVMD
TS

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About TS Tenaris S.A.

Tenaris SA is engaged in the manufacture and supply of steel pipe products and related services for the energy industry and other industrial applications. The company has one reportable segment, Tubes, which includes the production and sale of steel tubular products such as OCTG, line pipe, and mechanical and structural tubes, mainly for the oil and gas industry. It operates an integrated network of manufacturing, research, and service facilities across the Americas, Europe, the Middle East, Asia, and Africa.

Share on Social Networks: